
News|Articles|April 1, 2002
Why physicians start or stop prescribing a drug: Literature review and formulary implications (PDF)
These authors report on their literature search of studies assessing the impact of factors influencing the diffusion of new drug therapies and physicians' adoption and eventual relinquishment of those therapies. They specifically explore how their finds can help better align physician prescribing with formulary objectives.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Robyn Crosson, J.D., Navitus Health Solutions
2
Yesafili, an Eylea biosimilar, launches with a price of $1,445
3
A conversation about using GLP-1s to manage antipsychotic weight gain, with Mahavir Agarwal, M.D., Ph.D.
4
Ashley Holzworth-Nash, Pharm.D., Evernorth
5






















